Get the Stockscreener App
3.30
4.10%
0.13
Apyx Medical Corp stock is traded at $3.30, with a volume of 30,306.
It is up +4.10% in the last 24 hours and down -16.88% over the past month.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
See More
Previous Close:
$3.17
Open:
$3.17
24h Volume:
30,306
Relative Volume:
0.31
Market Cap:
$135.40M
Revenue:
$52.35M
Net Income/Loss:
$-18.71M
P/E Ratio:
-6.1111
EPS:
-0.54
Net Cash Flow:
$-5.78M
1W Performance:
-3.51%
1M Performance:
-16.88%
6M Performance:
+60.98%
1Y Performance:
+177.31%
1-Day Range:
$3.17
$3.345
1-Week Range:
$3.11
$3.53
52-Week Range:
$0.7554
$4.50
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
(727) 384-2323
Address
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
3.30 | 130.06M | 52.35M | -18.71M | -5.78M | -0.54 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Roth Capital | Buy |
| Nov-14-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Nov-12-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Oct-17-24 | Initiated | BTIG Research | Neutral |
| Jul-14-23 | Initiated | Stephens | Overweight |
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
View All
Apyx Medical Corp Stock (APYX) Latest News
Apyx Medical (APYX) to Release Quarterly Earnings on Thursday - MarketBeat
APYX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Should You Buy Apyx Medical Inc (APYX) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Breakout Watch: Can Apyx Medical Corporation keep up with sector leadersTrend Reversal & Daily Price Action Insights - baoquankhu1.vn
Risks Report: Is Apyx Medical Corporation currently under institutional pressureEarnings Risk Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
APYX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026 - The Manila Times
Surgical aesthetics maker Apyx to share Q4 2025 results in March 10 call - Stock Titan
APYX MEDICAL : TO RELEASE FOURTH QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 10, 2026 - marketscreener.com
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference - GlobeNewswire
Surgical aesthetics firm Apyx to meet investors, livestream chat from Miami - Stock Titan
Apyx Medical (NASDAQ:APYX) Trading 3.2% HigherHere's What Happened - MarketBeat
Growth Recap: Why is Apyx Medical Corporation stock going upWeekly Profit Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
APYX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Subdued Growth No Barrier To Apyx Medical Corporation (NASDAQ:APYX) With Shares Advancing 26% - simplywall.st
Technical Analysis: Is Apyx Medical Corporation a potential multi baggerJuly 2025 Selloffs & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Apyx Medical Corporation to Participate at the BTIG 13th - GlobeNewswire
Surgical aesthetics maker Apyx heads to BTIG’s 2026 medtech summit - stocktitan.net
Chuck Royce's Recent Transaction with Apyx Medical Corp: An In-D - GuruFocus
How Evolving Valuation Views Are Rewriting The Story For Apyx Medical (APYX) - Yahoo Finance
Apyx Medical Stock Strengthens On AYON Launch And U.S. Aesthetics Demand - RTTNews
Apyx Medical reports 34% revenue growth in Q4 2025 - Investing.com
Quarterly Earnings: How liquid is Apyx Medical Corporation stock2025 Sector Review & Daily Stock Trend Watchlist - baoquankhu1.vn
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewswire
How Apyx Medical Corporation stock benefits from global expansionJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - Улправда
Why Apyx Medical Corporation stock is popular among millennials2025 Market Sentiment & AI Forecasted Entry and Exit Points - Улправда
How The AYON Story Is Reshaping The Apyx Medical (APYX) Investment Case - Yahoo Finance
Apyx Medical (APYX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What The AYON Launch Means For Apyx Medical’s Evolving Story And Valuation - Yahoo Finance
Apyx Medical prices $10 million public offering of common stock - MSN
Apyx Medical (NASDAQ:APYX) Upgraded at Zacks Research - MarketBeat
Apyx Medical Corporation (NASDAQ:APYX) Supports Modern Surgical Care - Kalkine Media
Apyx Medical (NASDAQ:APYX) Upgraded at Roth Capital - Defense World
Apyx Medical (NASDAQ:APYX) Stock Rating Upgraded by Roth Capital - MarketBeat
[EFFECT] Apyx Medical Corp SEC Filing - Stock Titan
APYX Analyst Forecasts - Quiver Quantitative
Roth Capital Initiates Coverage on APYX with a 'Buy' Rating | AP - GuruFocus
Roth/MKM initiates coverage on Apyx Medical stock with Buy rating - Investing.com Nigeria
Apyx Medical files amendment to certificate of incorporation with Delaware - Investing.com
How AYON Momentum Is Rewriting the Growth Story for Apyx Medical - Yahoo Finance
Apyx Medical launches Apyx One console in South Korea - Investing.com
Apyx Medical Corporation Announces Approval and Commercial - GlobeNewswire
Apyx Medical (Nasdaq: APYX) gains MFDS OK, to ship Apyx One to Korea in Q4 2025 - Stock Titan
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Yahoo Finance
Why Apyx Medical Corporation stock remains on watchlistsVolume Spike & Verified Chart Pattern Signals - Newser
US Stocks Recap: How Apyx Medical Corporation stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Chart Pattern Signals - moha.gov.vn
Taking on analysts’ expectations and winning: Apyx Medical Corp (APYX) - Setenews
What hedge fund activity signals for Apyx Medical Corporation stockJuly 2025 Final Week & Consistent Profit Trade Alerts - BỘ NỘI VỤ
Looking at the Narrative for Apyx Medical After AYON System Momentum and Analyst Upgrades - Yahoo Finance
Wall Street Zen Upgrades Apyx Medical (NASDAQ:APYX) to “Hold” - Defense World
Wall Street Zen Upgrades Apyx Medical (NASDAQ:APYX) to "Hold" - MarketBeat
Apyx Medical Corp Stock (APYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):